BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation.
Sign Up to like & getrecommendations! Published in 2023 at "Endocrine-related cancer"
DOI: 10.1530/erc-22-0344
Abstract: Anaplastic thyroid cancer (ATC) is a rare but fatal cancer with BRAF mutation ranging from 30%-50%. Histone lysine lactylation represents a novel epigenetic mark that translates cellular metabolic signals into transcriptional regulation. It is not… read more here.
Keywords: cellular lactylation; proliferation; brafv600e; lactylation ... See more keywords